Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pilar María Luque Navarro

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Molecules (Basel, Switzerland)|February 23, 2020
Flow Synthesis of Biologically-Relevant Compound LibrariesPilar María Luque Navarro, Daniela Lanari
Pharmaceutics|September 28, 2021
Anticancer and Structure Activity Relationship of Non-Symmetrical Choline Kinase InhibitorsSantiago Schiaffino-Ortega, Elena Mariotto, Pilar María Luque-Navarro, et al.
Pharmaceutics|November 27, 2021
New Compounds with Bioisosteric Replacement of Classic Choline Kinase Inhibitors Show Potent Antiplasmodial ActivityFrancisco José Aguilar-Troyano, Archimede Torretta, Gianluca Rubbini, et al.
Pharmaceutics|April 23, 2022
Biological Evaluation of New Thienopyridinium and Thienopyrimidinium Derivatives as Human Choline Kinase InhibitorsPilar María Luque-Navarro, Elena Mariotto, Marco Ballarotto, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Molecules (Basel, Switzerland)|February 23, 2020
Flow Synthesis of Biologically-Relevant Compound LibrariesPilar María Luque Navarro, Daniela Lanari
Pharmaceutics|September 28, 2021
Anticancer and Structure Activity Relationship of Non-Symmetrical Choline Kinase InhibitorsSantiago Schiaffino-Ortega, Elena Mariotto, Pilar María Luque-Navarro, et al.
Pharmaceutics|November 27, 2021
New Compounds with Bioisosteric Replacement of Classic Choline Kinase Inhibitors Show Potent Antiplasmodial ActivityFrancisco José Aguilar-Troyano, Archimede Torretta, Gianluca Rubbini, et al.
Pharmaceutics|April 23, 2022
Biological Evaluation of New Thienopyridinium and Thienopyrimidinium Derivatives as Human Choline Kinase InhibitorsPilar María Luque-Navarro, Elena Mariotto, Marco Ballarotto, et al.
Pageof 1